2022
DOI: 10.1007/978-3-031-06566-8_13
|View full text |Cite
|
Sign up to set email alerts
|

PI3K and AKT at the Interface of Signaling and Metabolism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
2

Relationship

2
3

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 155 publications
0
11
0
Order By: Relevance
“…The PI3K-Akt signaling pathway is a key node for controlling the cell growth, multiplication and metabolism in mammalian cells [Pompura & Dominguez-Villar, 2018]. The action of PI3K-Akt signaling pathway could induce cells to proliferate abnormally, and the inhibited PI3K-Akt signaling pathway resulted in growth defects [Solinas & Becattini, 2022]. Various studies have shown that PI3K-Akt signaling pathway could promote the proliferation and anti-apoptosis of immature germ cells [Deng, et al, 2021].…”
Section: Discussionmentioning
confidence: 99%
“…The PI3K-Akt signaling pathway is a key node for controlling the cell growth, multiplication and metabolism in mammalian cells [Pompura & Dominguez-Villar, 2018]. The action of PI3K-Akt signaling pathway could induce cells to proliferate abnormally, and the inhibited PI3K-Akt signaling pathway resulted in growth defects [Solinas & Becattini, 2022]. Various studies have shown that PI3K-Akt signaling pathway could promote the proliferation and anti-apoptosis of immature germ cells [Deng, et al, 2021].…”
Section: Discussionmentioning
confidence: 99%
“…In humans and rodents, induction of lipolysis with b-adrenergic agonists stimulates insulin secretion (Imura et al, 1971;Porte, 1967;Sennitt et al, 1985), and inhibition of lipolysis with nicotinic acid (NA) reduces insulin secretion in fasting (Balasse and Ooms, 1973;Boden et al, 1998;Dobbins et al, 1998a;Dobbins et al, 1998b;Stein et al, 1996). Considering the opposing actions of b-adrenergic signaling and InsR-PI3K signaling on adipocyte lipolysis (Guilherme et al, 2022;Solinas and Becattini, 2022), we hypothesized that insulin secretion is governed by adipocyte InsR-PI3K signaling.…”
Section: Introductionmentioning
confidence: 98%
“…This capacity of different species to precisely match insulin secretion with insulin sensitivity over a wide range of serum insulin indicates a conserved crosstalk between the metabolic action of insulin and insulin secretion. The metabolic action of insulin depends on the induction of phosphoinositide-3 kinase (PI3K) - AKT signaling in insulin target cells (Solinas and Becattini, 2022). Pharmacological inhibition of either the insulin receptor (InsR), PI3K, or AKT causes hyperglycemia and hyperinsulinemia in humans and rodents (Ando et al, 2014; Hopkins et al, 2018; Kalinsky et al, 2018; Patnaik et al, 2016; von Mehren et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In humans and rodents, induction of lipolysis with b-adrenergic agonists stimulates insulin secretion [19][20][21] , and inhibition of lipolysis with nicotinic acid (NA) reduces insulin secretion in fasting [22][23][24][25][26] . Considering the opposing actions of badrenergic signaling and InsR-PI3K signaling on adipocyte lipolysis 27,28 , we hypothesized that insulin secretion is governed by adipocyte InsR-PI3K signaling.…”
Section: Introductionmentioning
confidence: 99%